LY353381 in Preventing Breast Cancer in Women With Hyperplasia
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: arzoxifene|DRUG: Placebo
Sponsor: University of Kansas Medical Center
Collaborators: National Cancer Institute (NCI)